Synthesis, characterisation and invitro anticancer activity of thiazolidine-2,4-dione derivatives

Journal Title: Journal of Drug Discovery and Therapeutics - Year 2014, Vol 2, Issue 12

Abstract

Thiazolidine-2,4-diones exhibit broad spectrum of biological activities like antimicrobial, anticancer, anti-inflammatory, anti diabetic etc.The aim and objective of present study was to develop novel thiazolidine-2,4-diones hybrid analogues in favour of the molecular docking studies and to evaluate their cytotoxic activities. The molecular docking studies of the proposed derivatives were carried out using softwares - Argus lab, CORINA,swiss PDB and Molegro molecular viewer. The anti cancer targets used is PPAR-γ and those with better scores were selected and subjected for the wet lab synthesis. In this study, 5 novel thiazolidine-2,4-dione analogues were synthesized by the Knoevenangel condensation reaction of thiazolidine-2,4-diones with substituted aromatic aldehydes using L-Tyrosine as catalyst to yield 5-arylidine thiazolidine-2,4-diones,which on further undergo mannich reaction with aromatic amines to yield mannich bases. The purity of the newly synthesized compounds was ascertained by consistency in the TLC as well as melting point determination and was characterized by means of FTIR,1HNMR and MASS spectral analysis. Among the synthesized compounds, POD 1,POD 2, POD 3 with better scores were tested for in-vitro cytotoxicity studies by MTT assay on MCF-7 cell lines. Among this POD 1 and POD 2 exhibited significant activity on the cell line. Finally it was concluded that novel thiazolidine-2,4-diones hybrid analogues can be considered as the future lead molecule for drug discovery process.

Authors and Affiliations

T. T Akshaya*| Department of Pharmaceutical Chemistry, Devaki Amma Memorial College of Pharmacy, Pulliparamba (P.O), Chelembra, Malappuram-673634, Kerala, India, V. B Arunlal| Department of Pharmaceutical Chemistry, Devaki Amma Memorial College of Pharmacy, Pulliparamba (P.O), Chelembra, Malappuram-673634, Kerala, India, Dr. G. Babu| Department of Pharmaceutical Chemistry, Devaki Amma Memorial College of Pharmacy, Pulliparamba (P.O), Chelembra, Malappuram-673634, Kerala, India, Dr. Biju. C. R| Department of Pharmaceutical Chemistry, Devaki Amma Memorial College of Pharmacy, Pulliparamba (P.O), Chelembra, Malappuram-673634, Kerala, India

Keywords

Related Articles

CNS AGENTS ON HIV/AIDS: OVERVIEW

HIV/AIDS patients suffering from depression more often treated with various drugs like Methylphenidate, Dextroamphetamine to treat depression and also with psychoactive drugs to treat side effects like insomnia. Sometime...

JAHN-TELLER DISTORTIONS: A NEW STRATEGY IN QUANTUM MECHANICS

The concepts of the Jahn-Teller effect and vibronic coupling are being applied to more and more systems in both chemistry and physics. Aspects of structural chemistry such as the distortion of the nuclear framework to a...

DETRIMENTAL IMPACTS OF TOXIC INGREDIENTS FOUND IN COLAS

The pesticides-in-cola saga continues. The health ministry’s expert committee states Coke and Pepsi are safe, and has trashed the testing methodology of Centre for Science and Environment (CSE), the NGO that claimed to...

Effect of Momordica charantia L. leaves extract on biophysical and biochemical parameters of wound in experimentally induced diabetes in rats

Momordica charantia Linn. leave extrat in the form of an ointment (20% w/w dried powder in simple ointment base) was evaluated for wound-healing potential in an excision wound model whereas the the leave extract given or...

BILATERAL CONGENITAL GLAUCOMA IN NEUROFIBROMATOSIS TYPE 1 AND MANAGEMENT. (A RARE - CASE REPORT)

Neurofibromatosis 1 is a genetic disorder of neural crest-derived cells. Riccardi classified NF into 8 subtypes NF-I to NF-VIII. NF-V is segmental NF (Prevalence 0.0014 and 0.002%) Caused by a Postzygotic somatic mutatio...

Download PDF file
  • EP ID EP1558
  • DOI -
  • Views 474
  • Downloads 42

How To Cite

T. T Akshaya*, V. B Arunlal, Dr. G. Babu, Dr. Biju. C. R (2014). Synthesis, characterisation and invitro anticancer activity of thiazolidine-2,4-dione derivatives. Journal of Drug Discovery and Therapeutics, 2(12), 42-47. https://europub.co.uk/articles/-A-1558